Guide to Biosimilars Litigation and Regulation in the U.S.

Guide to Biosimilars Litigation and Regulation in the U.S.
Author :
Publisher :
Total Pages : 686
Release :
ISBN-10 : 153928672X
ISBN-13 : 9781539286721
Rating : 4/5 (721 Downloads)

Book Synopsis Guide to Biosimilars Litigation and Regulation in the U.S. by : Robert V. Cerwinski

Download or read book Guide to Biosimilars Litigation and Regulation in the U.S. written by Robert V. Cerwinski and published by . This book was released on 2019 with total page 686 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Guide to Biosimilars Litigation and Regulation in the U.S. Related Books

Guide to Biosimilars Litigation and Regulation in the U.S.
Language: en
Pages: 686
Authors: Robert V. Cerwinski
Categories: Drugs
Type: BOOK - Published: 2019 - Publisher:

DOWNLOAD EBOOK

Guide to Biosimilars Litigation and Regulation in the U.S.
Language: en
Pages: 0
Authors:
Categories: Drugs
Type: BOOK - Published: 2022 - Publisher:

DOWNLOAD EBOOK

Biosimilars
Language: en
Pages: 709
Authors: Hiten J. Gutka
Categories: Medical
Type: BOOK - Published: 2018-12-13 - Publisher: Springer

DOWNLOAD EBOOK

This book provides a comprehensive overview of the biosimilar regulatory framework, the development process and clinical aspects for development of biosimilars.
Promoting Access to Medical Technologies and Innovation - Intersections between Public Health, Intellectual Property and Trade
Language: en
Pages: 259
Authors: World Intellectual Property Organization
Categories: Law
Type: BOOK - Published: 2013 - Publisher: WIPO

DOWNLOAD EBOOK

This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in develop
The Business of Healthcare Innovation
Language: en
Pages: 400
Authors: Lawton R. Burns
Categories: Business & Economics
Type: BOOK - Published: 2005-08-25 - Publisher: Cambridge University Press

DOWNLOAD EBOOK

The first wide-ranging analysis of business trends in the manufacturing segment of the health care industry.